Type 2 & other diabetes

Effects of the ABCC8 R1420H loss-of-function variant on beta-cell function, diabetes incidence, and retinopathy

BMJ Open Diabetes Res CarePublished Longitudinal cohort study

Authors' conclusion

The ABCC8 R1420H variant is associated with increased risks of diabetes and of retinopathy, which may be partially explained by higher glycemia levels and worse beta-cell function.

Study context

Population
American Indians previously genotyped for R1420H with available phenotypic data; beta-cell function analysed in those without diabetes aged ≥5 years; median follow-up 13.5 years (IQR 4.5–26.8)254 variant carriers
Participants
7,675 participants
Exposure
ABCC8 R1420H variant carriers vs non-carriers
  • Carriersn = 254
Outcome
Beta-cell function (insulin secretion vs insulin sensitivity)
Methodological detailscross-sectional analyses of diabetes complications, hierarchical logistic regression, standard major axis regression
  • Cross-sectional analyses of diabetes complications
  • Hierarchical logistic regression
  • Standard major axis regression

Main finding

As reported in the abstract

  • Worse beta-cell function in carriers, in children and adults
  • Insulin sensitivity: no difference (p=0.50)
  • Carriers vs Non-carriers: P = 0.0004

Observational data: associations, not effects.

Further findings

Insulin sensitivity

No difference in insulin sensitivity, carriers vs non-carriers
P = 0.50

T2D incidence

At any BMI and age before 35 years, carriers had higher T2D incidence

Prevalence of increased albuminuria (albumin-to-creatinine ratio (ACR) ≥30 mg/g)

Variant not associated with prevalence of increased albuminuria, OR
0.87 (0.66 to 1.16) (95% CI)

Prevalence of severe albuminuria (ACR ≥300 mg/g)

Variant not associated with prevalence of severe albuminuria, OR
0.96 (0.55 to 1.68) (95% CI)

Prevalence of reduced eGFR (<60 mL/min/1.73 m²)

Variant not associated with prevalence of reduced eGFR, OR
0.44 (0.18 to 1.06) (95% CI)

Retinopathy prevalence

Variant significantly associated with higher retinopathy prevalence, OR
1.74 (1.19 to 2.53) (95% CI)
Association only partially mediated by glycemia, duration of diabetes, retinopathy risk factors or insulin use
<11%
Retinopathy prevalence in carriers higher regardless of diabetes presence

Original publication

Effects of the ABCC8 R1420H loss-of-function variant on beta-cell function, diabetes incidence, and retinopathy. BMJ Open Diabetes Res Care. Published 12 December 2023. doi:10.1136/bmjdrc-2023-003700

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.